Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

4.70
Delayed Data
As of Dec 09
 +0.10 / +2.17%
Today’s Change
3.50
Today|||52-Week Range
10.36
-34.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization162.0K146.0K138.0K133.0K
 
 
 
 
 
 
Operating ExpensesGross Income-162.0K-146.0K-138.0K-133.0K
 
 
 
 
 
General Expenses5.1M5.4M5.6M5.7M
 
 
 
 
 
Research And Development2.8M2.6M2.8M3.3M
 
 
 
 
 
Total Operating Expenses5.3M5.6M5.8M5.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.3M-5.6M-5.8M-5.9M
 
 
 
 
 
Extraordinary Credit545.0K0.00595.0K0.00
 
 
 
Extraordinary Charge0.00-1.0M0.00-336.0K
 
 
 
Interest Expense On Debt75.0K63.0K29.0K32.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.7M-6.6M-5.2M-6.2M
 
 
 
 
 
Net Income-4.7M-6.6M-5.2M-6.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.6M28.2M31.9M32.0M
 
 
 
 
 
Shares To Calculate EPS Diluted27.6M28.2M31.9M32.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.24-$0.16-$0.19
 
 
 
 
 
EPS Diluted-$0.17-$0.24-$0.16-$0.19